EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 43 filers reported holding EVELO BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $51,000 | -48.0% | 15,079 | -6.6% | 0.00% | – |
| Q4 2021 | $98,000 | -16.2% | 16,140 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $117,000 | -50.0% | 16,623 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $234,000 | +62.5% | 17,018 | +26.8% | 0.00% | 0.0% |
| Q1 2021 | $144,000 | +2.9% | 13,422 | +15.5% | 0.00% | 0.0% |
| Q4 2020 | $140,000 | +122.2% | 11,621 | -2.8% | 0.00% | – |
| Q3 2020 | $63,000 | +50.0% | 11,955 | +39.5% | 0.00% | – |
| Q2 2020 | $42,000 | +35.5% | 8,568 | +5.3% | 0.00% | – |
| Q1 2020 | $31,000 | -11.4% | 8,137 | -5.5% | 0.00% | – |
| Q4 2019 | $35,000 | -34.0% | 8,608 | -0.8% | 0.00% | – |
| Q3 2019 | $53,000 | -32.1% | 8,680 | -0.7% | 0.00% | – |
| Q2 2019 | $78,000 | +11.4% | 8,741 | -0.6% | 0.00% | – |
| Q1 2019 | $70,000 | -40.7% | 8,791 | -3.2% | 0.00% | – |
| Q4 2018 | $118,000 | +174.4% | 9,077 | +155.2% | 0.00% | – |
| Q3 2018 | $43,000 | +4.9% | 3,557 | +1.8% | 0.00% | – |
| Q2 2018 | $41,000 | – | 3,494 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 18,233,403 | $215,154,000 | 41.21% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $20,809,000 | 26.29% |
| Alphabet Inc. | 1,060,495 | $12,514,000 | 1.05% |
| SECTORAL ASSET MANAGEMENT INC | 437,500 | $5,163,000 | 0.58% |
| DC Investments Management, LLC | 36,924 | $436,000 | 0.28% |
| ARK Investment Management | 126,831 | $1,497,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 22,998 | $271,000 | 0.03% |
| Laurion Capital Management LP | 150,000 | $1,770,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 9,380 | $111,000 | 0.01% |
| CREDIT SUISSE AG/ | 440,169 | $5,194,000 | 0.01% |